Literature DB >> 4256452

Susceptibility to leukemia: immunologic factors in Down's syndrome.

A I Sutnick, W T London, B S Blumberg, B J Gerstley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4256452

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  Malignancies in Down syndrome.

Authors:  P Kusumakumary; T S Vats; R Ankathil; H R Gattamaneni; M K Nair
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

2.  Monoclonal antibody defined T cell subsets and autologous mixed lymphocyte reaction in Down's syndrome.

Authors:  S Gupta; S M Fikrig; E Mariano; Q Quazi
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

3.  Down's syndrome: changes in protein fractions of blood plasma.

Authors:  J Kedziora; M Soszyński; G Bartosz; H Witas; W Leyko
Journal:  Experientia       Date:  1980-08-15

4.  Familial acute myeloid leukaemia with acquired Pelger-Huet anomaly and aneuploidy of C group.

Authors:  J Kaur; D Catovsky; H Valdimarsson; O Jensson; A S Spiers
Journal:  Br Med J       Date:  1972-11-11

5.  Immunological and virological investigations in Down's syndrome.

Authors:  G Fekete; G Kulcsár; P Dán; I Nász; D Schuler; M Dobos
Journal:  Eur J Pediatr       Date:  1982-02       Impact factor: 3.183

6.  Family studies in acute leukaemia in childhood: a possible association with autoimmune disease.

Authors:  M Till; N Rapson; P G Smith
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

7.  Childhood and maternal infections and risk of acute leukaemia in children with Down syndrome: a report from the Children's Oncology Group.

Authors:  K N Canfield; L G Spector; L L Robison; D Lazovich; M Roesler; A F Olshan; F O Smith; N A Heerema; D R Barnard; C K Blair; J A Ross
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.